Simplex Trading’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.98K | Sell |
3,060
-13,394
| -81% | -$21.3K | ﹤0.01% | 8301 |
|
|
2026
Q1 | $26.7K | Buy |
+16,454
| New | +$33.8K | ﹤0.01% | 6510 |
|
|
2025
Q4 | – | Sell |
-9,053
| Closed | -$21K | – | 8776 |
|
|
2025
Q3 | $18K | Sell |
9,053
-55,467
| -86% | -$153K | ﹤0.01% | 7397 |
|
|
2025
Q2 | $203K | Sell |
64,520
-58,913
| -48% | -$180K | ﹤0.01% | 4487 |
|
|
2025
Q1 | $387K | Buy |
123,433
+96,369
| +356% | +$381K | ﹤0.01% | 3669 |
|
|
2024
Q4 | $117K | Buy |
27,064
+14,493
| +115% | +$45.3K | ﹤0.01% | 5037 |
|
|
2024
Q3 | $33K | Sell |
12,571
-12,074
| -49% | -$28.5K | ﹤0.01% | 6259 |
|
|
2024
Q2 | $54K | Sell |
24,645
-12,946
| -34% | -$48.8K | ﹤0.01% | 6002 |
|
|
2024
Q1 | $200K | Buy |
+37,591
| New | +$99.9K | ﹤0.01% | 4866 |
|
|
2023
Q4 | – | Sell |
-15,551
| Closed | -$18.8K | – | 8913 |
|
|
2023
Q3 | $21K | Buy |
+15,551
| New | +$26.2K | ﹤0.01% | 6566 |
|
|
2023
Q1 | – | Sell |
-10,500
| Closed | -$18K | – | 9161 |
|
|
2022
Q4 | $14K | Sell |
10,500
-11,605
| -52% | -$16.6K | ﹤0.01% | 7205 |
|
|
2022
Q3 | $34K | Sell |
22,105
-44,440
| -67% | -$107K | ﹤0.01% | 6918 |
|
|
2022
Q2 | $146K | Buy |
66,545
+40,038
| +151% | +$67.1K | ﹤0.01% | 5038 |
|
|
2022
Q1 | $65K | Sell |
26,507
-33,629
| -56% | -$119K | ﹤0.01% | 6765 |
|
|
2021
Q4 | $361K | Buy |
60,136
+55,676
| +1,248% | +$332K | ﹤0.01% | 4282 |
|
|
2021
Q3 | $29K | Sell |
4,460
-346
| -7% | -$2.17K | ﹤0.01% | 8114 |
|
|
2021
Q2 | $31K | Buy |
+4,806
| New | +$40.8K | ﹤0.01% | 8193 |
|
|
2021
Q1 | – | Sell |
-404
| Closed | -$4.91K | – | 8977 |
|
|
2020
Q4 | $7K | Buy |
+404
| New | +$7.1K | ﹤0.01% | 7569 |
|
|
2017
Q4 | – | Sell |
-65
| Closed | -$3K | – | 6068 |
|
|
2017
Q3 | $3K | Buy |
65
+48
| +282% | +$2.99K | ﹤0.01% | 4748 |
|
|
2017
Q2 | $1K | Sell |
17
-3
| -15% | -$193 | ﹤0.01% | 5556 |
|
|
2017
Q1 | $1K | Sell |
20
-18
| -47% | -$2.44K | ﹤0.01% | 5583 |
|
|
2016
Q4 | $5K | Sell |
38
-143
| -79% | -$33.4K | ﹤0.01% | 4320 |
|
|
2016
Q3 | $58K | Sell |
181
-36
| -17% | -$13.1K | ﹤0.01% | 1972 |
|
|
2016
Q2 | $70K | Sell |
217
-2
| -0.9% | -$689 | ﹤0.01% | 1744 |
|
|
2016
Q1 | $73K | Buy |
219
+183
| +508% | +$62.3K | 0.01% | 1615 |
|
|
2015
Q4 | $14K | Buy |
+36
| New | +$14.1K | ﹤0.01% | 3002 |
|
Other funds holding CRDF
LCM
P
Simplex Trading's CRDF Position: Q2 2026 in Review
Simplex Trading reduced its Cardiff Oncology (CRDF) stake by 81% in Q2 2026, selling an estimated $21.3K and leaving 3,060 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #8301.
Simplex Trading first reported a position in CRDF in Q4 2015 and has held it in 26 quarters since. The position peaked at $387K in Q1 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Simplex Trading held 3,060 shares of Cardiff Oncology worth $3.98K as of Q2 2026.
- Simplex Trading sold 13,394 Cardiff Oncology shares in Q2 2026, an estimated $21.3K.
- Cardiff Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8301 holding.
- Simplex Trading first reported a position in Cardiff Oncology in Q4 2015 and has held it in 26 quarters since.
- Simplex Trading's Cardiff Oncology position peaked at $387K in Q1 2025.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.